Hassane M Zarour Selected Research

Hassane M Zarour Research Topics

Disease

36	Neoplasms (Cancer) 10/2022 - 01/2002
30	Melanoma (Melanoma, Malignant) 01/2022 - 01/2002
2	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Disease Progression 01/2020
1	Nevus (Nevi) 01/2018
1	Leukemia 04/2016
1	Lymphoma (Lymphomas) 04/2016
1	Virus Diseases (Viral Diseases) 04/2016
1	Human Influenza (Influenza) 05/2009

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2022 - 01/2002
10	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2008
9	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2002
8	VaccinesIBA 01/2021 - 03/2003
8	EpitopesIBA 02/2012 - 01/2002
7	Immune Checkpoint InhibitorsIBA 10/2022 - 09/2010
7	AntigensIBA 01/2022 - 09/2002
6	Cancer VaccinesIBA 02/2014 - 01/2002
5	LigandsIBA 01/2020 - 05/2013
5	HLA-DR Antigens (HLA-DR)IBA 12/2007 - 01/2002
4	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
4	CytokinesIBA 05/2013 - 03/2003
4	Immunodominant EpitopesIBA 01/2011 - 05/2002
3	CTLA-4 AntigenIBA 10/2022 - 05/2013
3	pembrolizumabIBA 01/2022 - 10/2018
2	MucinsIBA 01/2022 - 01/2020
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 05/2015
2	B7-H1 AntigenIBA 01/2020 - 05/2009
2	Monoclonal AntibodiesIBA 01/2020 - 01/2020
2	AntibodiesIBA 11/2015 - 01/2002
2	Interleukin-10 (Interleukin 10)IBA 04/2015 - 05/2013
2	Interleukin-2 (IL2)IBA 09/2010 - 07/2008
2	InterferonsIBA 07/2008 - 09/2002
2	HLA-DP Antigens (HLA-DP)IBA 12/2007 - 02/2005
2	HLA-DRB1*04:01 antigenIBA 10/2003 - 01/2002
2	AutoantigensIBA 05/2002 - 01/2002
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	incomplete Freund's adjuvantIBA 01/2021
1	poly ICLCIBA 01/2021
1	IpilimumabIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	peginterferon alfa-2b (Pegintron)FDA Link 10/2018
1	DecorinIBA 01/2018
1	sulforaphaneIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Chimeric Antigen ReceptorsIBA 04/2016
1	Blocking AntibodiesIBA 11/2015
1	Mitogen-Activated Protein KinasesIBA 11/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2013
1	Amino Acids FDA Link 05/2013
1	Tumor Viral Antigens (Large T Antigen)IBA 05/2013
1	EnzymesIBA 05/2013
1	MART-1 AntigenIBA 05/2009
1	mannide monooleateIBA 10/2008
1	Monatide (IMS 3015)IBA 10/2008
1	ProMune (CpG 7909)IBA 10/2008
1	Adenosine (Adenocard)FDA LinkGeneric 06/2007
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2006
1	HLA-DPw4 antigenIBA 02/2005
1	Interleukin-5 (Interleukin 5)IBA 02/2005
1	Histocompatibility Antigens Class IIIBA 09/2002
1	Sulfhydryl Compounds (Thiols)IBA 05/2002
1	Oxidoreductases (Dehydrogenase)IBA 05/2002
1	Interferon-gamma (Interferon, gamma)IBA 05/2002

Therapy/Procedure

13	Immunotherapy 10/2022 - 06/2007
13	Therapeutics 10/2022 - 07/2008
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2020
2	Immunomodulation 01/2022 - 07/2008
2	Radiotherapy 01/2020 - 11/2015
1	Fecal Microbiota Transplantation 01/2021
1	Chemoprevention 01/2018